“…For immunohistochemistry, sections were treated for 30 min in 0.1% H 2 O 2 /methanol at 20°C, and then blocked (5% serum of host of secondary antibody/5% nonfat dry milk/0.1% Triton X-100/PBS) and incubated with primary antibody overnight at 4°C. The primary antibodies used were: p75 NTR (extracellular domain-directed: R&D Systems, 1:1,000; intracellular domain-directed: Promega, 1:500), proNGF (prodomain-specific, 1:100; Harrington et al, 2004), sortilin (R&D, 1:400), SorCS2 (intracellular domain-directed: generated by immunizing rabbits against huSorCS2 aa 1138-1159, coupled to KLH, 1:300; or extracellular domain directed: R&D Systems, 1:100), CD140b (PDGFR-, eBioscience, 1:200), IB4 (preconjugated to biotin, Vector Laboratories, 1:300), activated caspase-3 (Cell Signaling Technology, 1:200), tyrosine hydroxylase (Millipore, 1:150), CD31 (BD, 1:100), CD41 (BD, 1:100), fibrin(ogen) (FITCconjugated, Dako, 1:250), CD68 (TRITC-conjugated, Serotec, 1:100), CD45 (BD,1:200), and Gr1 (BD,1:200). Biotinylated secondary antibodies were conjugated to ABC reagent and detected using the VIP Peroxidase Substrate kit (Vector Laboratories).…”